Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Jun ^a   Tan, Lan ^a,b,c,d   Tan, Lin ^b   Tian, Yan ^a   Ma, Jing ^a   Tan, Chen Chen ^a   Wang, Hui Fu ^c   Liu, Ying ^d   Tan, Meng Shan ^b   Jiang, Teng ^e   Yu, Jin Tai ^a,b,c  

^a QINGDAO UNIVERSITY   (China)

^b OCEAN UNIVERSITY OF CHINA   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

^d DALIAN MEDICAL UNIVERSITY   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; BLOOD; DRUG RESISTANCE; EPILEPSY; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; YOUNG ADULT;

ADULT; BIOMARKERS; DRUG RESISTANCE; EPILEPSY; FEMALE; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; ROC CURVE; YOUNG ADULT;

EID: 84929629529     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10201     Document Type: Article

References (41)

1. Moshe, S. L., Perucca, E., Ryvlin, P. & Tomson, T. Epilepsy: new advances. Lancet doi:10.1016/S0140-6736 (14) 60456-6 (2014).
2. Devinsky, O. Patients with Refractory Seizures. N. Engl. J. Med. 340, 1565-1570 (1993).
3. Kwan, P. & Brodie, M. J. Early identification of refractory epilepsy. N. Engl. J. Med. 342, 314-319 (2000).
4. Chen, X. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006 (2008).
5. ElSharawy, A. et al. Genome-wide miRNA signatures of human longevity. Aging. Cell 11, 607-616 (2012).
6. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. USA 105, 10513-10518 (2008).
7. Cardo, L. F. et al. Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls. J. Neurol. 260, 1420-1422 (2013).
8. Gandhi, R. et al. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann. Neurol. 73, 729-740 (2013).
9. Tan, L. et al. Circulating miR-125b as a biomarker of Alzheimer's disease. J. Neurol. Sci. 336, 52-56 (2013).
10. Song, Y. J. et al. Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b. Brain Res. 1387, 134-140 (2011).
11. Hu, K. et al. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci. 13, 115 (2012).
12. Kan, A. A. et al. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell. Mol. Life Sci. 69, 3127-3145 (2012).
13. McKiernan, R. C. et al. Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS One 7, e35921 (2012).
14. Bot, A. M., Debski, K. J. & Lukasiuk, K. Alterations in miRNA levels in the dentate gyrus in epileptic rats. PLoS One 8, e76051 (2013).
15. Gorter, J. A. et al. Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol. Dis. 62, 508-520 (2014).
16. Li, M. M. et al. Genome-wide microRNA expression profiles in hippocampus of rats with chronic temporal lobe epilepsy. Sci. Rep. 4, 4734 (2014).
17. Sun, Z. et al. Genome-wide microRNA profiling of rat hippocampus after status epilepticus induced by amygdala stimulation identifies modulators of neuronal apoptosis. PLoS One 8, e78375 (2013).
18. Henshall, D. C. MicroRNA and epilepsy: profiling, functions and potential clinical applications. Curr Opin Neurol 27, 199-205 (2014).
19. Iyer, A. et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One 7, e44789 (2012).
20. Tan, L. et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease. J. Alzheimers. Dis. 40, 1017-1027 (2014).
21. Proper, E. A. et al. Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125, 32-43 (2002).
22. Cross, J. H., Boyd, S. G., Gordon, I., Harper, A. & Neville, B. G. Ictal cerebral perfusion related to EEG in drug resistant focal epilepsy of childhood. J. Neurol. Neurosurg. Psychiatry. 62, 377-384 (1997).
23. Holmes, G. L. EEG abnormalities as a biomarker for cognitive comorbidities in pharmacoresistant epilepsy. Epilepsia 54 Suppl 2, 60-62 (2013).
24. Aronica, E. et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur. J. Neurosci. 31, 1100-1107 (2010).
25. Nudelman, A. S. et al. Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 20, 492-498 (2010).
26. Liu, D. Z. et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 30, 92-101 (2010).
27. Wieser, H. G. & Epilepsy, I. C. o. N. o. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45, 695-714 (2004).
28. Lu, Z. et al. miR-301a as an NF-kappaB activator in pancreatic cancer cells. EMBO J. 30, 57-67 (2011).
29. Kumar, P. et al. Circulating miRNA biomarkers for Alzheimer's disease. PLoS One 8, e69807 (2013).
30. Kosik, K. S. The neuronal microRNA system. Nat. Rev. Neurosci. 7, 911-920 (2006).
31. Wayman, G. A. et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl. Acad. Sci. USA 105, 9093-9098 (2008).
32. Edbauer, D. et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65, 373-384 (2010).
33. Gaughwin, P., Ciesla, M., Yang, H., Lim, B. & Brundin, P. Stage-specific modulation of cortical neuronal development by MmumiR-134. Cereb. Cortex. 21, 1857-1869 (2011).
34. Tao, J. et al. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J. Neurosci. 31, 8306-8319 (2011).
35. O'Donoghue, M. F., Duncan, J. S. & Sander, J. W. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia 37, 563-571 (1996).
36. Engel, J., Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42, 796-803 (2001).
37. Kwan, P. et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Terapeutic Strategies. Epilepsia 51, 1069-1077 (2010).
38. Yu, S. et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 97, 2084-2092 (2012).
39. Yang, C. et al. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Int J Cancer 132, 116-127 (2013).
40. McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K. & Algeciras-Schimnich, A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 57, 833-840 (2011).
41. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 25, 402-408 (2001).